Literature DB >> 25987256

Disruption of the 5S RNP-Mdm2 interaction significantly improves the erythroid defect in a mouse model for Diamond-Blackfan anemia.

P Jaako1,2, S Debnath1, K Olsson1, Y Zhang3, J Flygare1, M S Lindström4, D Bryder2, S Karlsson1.   

Abstract

Diamond-Blackfan anemia (DBA) is a congenital erythroid hypoplasia caused by haploinsufficiency of genes encoding ribosomal proteins (RPs). Perturbed ribosome biogenesis in DBA has been shown to induce a p53-mediated ribosomal stress response. However, the mechanisms of p53 activation and its relevance for the erythroid defect remain elusive. Previous studies have indicated that activation of p53 is caused by the inhibition of mouse double minute 2 (Mdm2), the main negative regulator of p53, by the 5S ribonucleoprotein particle (RNP). Meanwhile, it is not clear whether this mechanism solely mediates the p53-dependent component found in DBA. To approach this question, we crossed our mouse model for RPS19-deficient DBA with Mdm2(C305F) knock-in mice that have a disrupted 5S RNP-Mdm2 interaction. Upon induction of the Rps19 deficiency, Mdm2(C305F) reversed the p53 response and improved expansion of hematopoietic progenitors in vitro, and ameliorated the anemia in vivo. Unexpectedly, disruption of the 5S RNP-Mdm2 interaction also led to selective defect in erythropoiesis. Our findings highlight the sensitivity of erythroid progenitor cells to aberrations in p53 homeostasis mediated by the 5S RNP-Mdm2 interaction. Finally, we provide evidence indicating that physiological activation of the 5S RNP-Mdm2-p53 pathway may contribute to functional decline of the hematopoietic system in a cell-autonomous manner over time.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25987256      PMCID: PMC4844018          DOI: 10.1038/leu.2015.128

Source DB:  PubMed          Journal:  Leukemia        ISSN: 0887-6924            Impact factor:   11.528


  32 in total

1.  Identification of new prognosis factors from the clinical and epidemiologic analysis of a registry of 229 Diamond-Blackfan anemia patients. DBA group of Société d'Hématologie et d'Immunologie Pédiatrique (SHIP), Gesellshaft für Pädiatrische Onkologie und Hämatologie (GPOH), and the European Society for Pediatric Hematology and Immunology (ESPHI).

Authors:  T N Willig; C M Niemeyer; T Leblanc; C Tiemann; A Robert; J Budde; A Lambiliotte; E Kohne; G Souillet; S Eber; J L Stephan; R Girot; P Bordigoni; G Cornu; S Blanche; J M Guillard; N Mohandas; G Tchernia
Journal:  Pediatr Res       Date:  1999-11       Impact factor: 3.756

Review 2.  Live or let die: the cell's response to p53.

Authors:  Karen H Vousden; Xin Lu
Journal:  Nat Rev Cancer       Date:  2002-08       Impact factor: 60.716

3.  Cancer-associated mutations in the MDM2 zinc finger domain disrupt ribosomal protein interaction and attenuate MDM2-induced p53 degradation.

Authors:  Mikael S Lindström; Aiwen Jin; Chad Deisenroth; Gabrielle White Wolf; Yanping Zhang
Journal:  Mol Cell Biol       Date:  2006-11-20       Impact factor: 4.272

4.  Ribosomal protein S24 gene is mutated in Diamond-Blackfan anemia.

Authors:  Hanna T Gazda; Agnieszka Grabowska; Lilia B Merida-Long; Elzbieta Latawiec; Hal E Schneider; Jeffrey M Lipton; Adrianna Vlachos; Eva Atsidaftos; Sarah E Ball; Karen A Orfali; Edyta Niewiadomska; Lydie Da Costa; Gil Tchernia; Charlotte Niemeyer; Joerg J Meerpohl; Joachim Stahl; Gerhard Schratt; Bertil Glader; Karen Backer; Carolyn Wong; David G Nathan; Alan H Beggs; Colin A Sieff
Journal:  Am J Hum Genet       Date:  2006-11-02       Impact factor: 11.025

5.  Improving clinical care and elucidating the pathophysiology of Diamond Blackfan anemia: an update from the Diamond Blackfan Anemia Registry.

Authors:  Jeffrey M Lipton; Eva Atsidaftos; Israel Zyskind; Adrianna Vlachos
Journal:  Pediatr Blood Cancer       Date:  2006-05-01       Impact factor: 3.167

6.  Expansion of hematopoietic stem cell phenotype and activity in Trp53-null mice.

Authors:  Michael TeKippe; David E Harrison; Jichun Chen
Journal:  Exp Hematol       Date:  2003-06       Impact factor: 3.084

7.  Ribosomal protein S17 gene (RPS17) is mutated in Diamond-Blackfan anemia.

Authors:  Radek Cmejla; Jana Cmejlova; Helena Handrkova; Jiri Petrak; Dagmar Pospisilova
Journal:  Hum Mutat       Date:  2007-12       Impact factor: 4.878

8.  Ribosomal mutations cause p53-mediated dark skin and pleiotropic effects.

Authors:  Kelly A McGowan; Jun Z Li; Christopher Y Park; Veronica Beaudry; Holly K Tabor; Amit J Sabnis; Weibin Zhang; Helmut Fuchs; Martin Hrabé de Angelis; Richard M Myers; Laura D Attardi; Gregory S Barsh
Journal:  Nat Genet       Date:  2008-07-20       Impact factor: 38.330

9.  The gene encoding ribosomal protein S19 is mutated in Diamond-Blackfan anaemia.

Authors:  N Draptchinskaia; P Gustavsson; B Andersson; M Pettersson; T N Willig; I Dianzani; S Ball; G Tchernia; J Klar; H Matsson; D Tentler; N Mohandas; B Carlsson; N Dahl
Journal:  Nat Genet       Date:  1999-02       Impact factor: 38.330

10.  Cells depleted for RPS19, a protein associated with Diamond Blackfan Anemia, show defects in 18S ribosomal RNA synthesis and small ribosomal subunit production.

Authors:  Rachel A Idol; Sara Robledo; Hong-Yan Du; Dan L Crimmins; David B Wilson; Jack H Ladenson; Monica Bessler; Philip J Mason
Journal:  Blood Cells Mol Dis       Date:  2007-03-21       Impact factor: 3.039

View more
  14 in total

1.  Delayed globin synthesis leads to excess heme and the macrocytic anemia of Diamond Blackfan anemia and del(5q) myelodysplastic syndrome.

Authors:  Zhantao Yang; Siobán B Keel; Akiko Shimamura; Li Liu; Aaron T Gerds; Henry Y Li; Brent L Wood; Bart L Scott; Janis L Abkowitz
Journal:  Sci Transl Med       Date:  2016-05-11       Impact factor: 17.956

2.  MYSM1 maintains ribosomal protein gene expression in hematopoietic stem cells to prevent hematopoietic dysfunction.

Authors:  Jad I Belle; HanChen Wang; Amanda Fiore; Jessica C Petrov; Yun Hsiao Lin; Chu-Han Feng; Thi Tuyet Mai Nguyen; Jacky Tung; Philippe M Campeau; Uta Behrends; Theresa Brunet; Gloria Sarah Leszinski; Philippe Gros; David Langlais; Anastasia Nijnik
Journal:  JCI Insight       Date:  2020-07-09

3.  Dynamic changes in murine erythropoiesis from birth to adulthood: implications for the study of murine models of anemia.

Authors:  Lixiang Chen; Jie Wang; Jing Liu; Hua Wang; Christopher D Hillyer; Lionel Blanc; Xiuli An; Narla Mohandas
Journal:  Blood Adv       Date:  2021-01-12

Review 4.  RNA Polymerases I and III in development and disease.

Authors:  Kristin En Watt; Julia Macintosh; Geneviève Bernard; Paul A Trainor
Journal:  Semin Cell Dev Biol       Date:  2022-04-11       Impact factor: 7.499

Review 5.  Nucleolus-derived mediators in oncogenic stress response and activation of p53-dependent pathways.

Authors:  Dariusz Stępiński
Journal:  Histochem Cell Biol       Date:  2016-05-03       Impact factor: 4.304

6.  Induction of the 5S RNP-Mdm2-p53 ribosomal stress pathway delays the initiation but fails to eradicate established murine acute myeloid leukemia.

Authors:  P Jaako; A Ugale; M Wahlestedt; T Velasco-Hernandez; J Cammenga; M S Lindström; D Bryder
Journal:  Leukemia       Date:  2016-06-03       Impact factor: 11.528

Review 7.  Targeting MDM2 for novel molecular therapy: Beyond oncology.

Authors:  Wei Wang; Jiang-Jiang Qin; Mehrdad Rajaei; Xin Li; Xiaoyi Yu; Courtney Hunt; Ruiwen Zhang
Journal:  Med Res Rev       Date:  2019-10-06       Impact factor: 12.944

Review 8.  Ribosome assembly coming into focus.

Authors:  Sebastian Klinge; John L Woolford
Journal:  Nat Rev Mol Cell Biol       Date:  2019-02       Impact factor: 94.444

9.  Mice with a Mutation in the Mdm2 Gene That Interferes with MDM2/Ribosomal Protein Binding Develop a Defect in Erythropoiesis.

Authors:  Takuya Kamio; Bai-wei Gu; Timothy S Olson; Yanping Zhang; Philip J Mason; Monica Bessler
Journal:  PLoS One       Date:  2016-04-04       Impact factor: 3.240

Review 10.  The importance of ribosome production, and the 5S RNP-MDM2 pathway, in health and disease.

Authors:  Andria Pelava; Claudia Schneider; Nicholas J Watkins
Journal:  Biochem Soc Trans       Date:  2016-08-15       Impact factor: 5.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.